Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

2485 ARTÍCULOS , VIENDO DEL 616 AL 630

The aggregation propensity of Tau and amyloid-β in Alzheimer's disease

Chinnathambi S, Kumarappan M, Chandrashekar M, Malik S.

Adv Protein Chem Struct Biol. 2025;146:179-199. doi: 10.1016/bs.apcsb.2024.10.004. Epub 2025 Apr 2.

Small-diffusible aggregates, plaques, tangles, and dynamic equilibria: Untangling Alzheimer's disease

Fertan E, Meisl G, Klenerman D.

Alzheimers Dement. 2025 Jul;21(7):e70462. doi: 10.1002/alz.70462.

Breaking the vicious cycle: bitter compounds targeting metabolic defects and inflammation in Alzheimer's disease

Wu H, He L, Dai L.

Am J Physiol Endocrinol Metab. 2025 Aug 1;329(2):E266-E275. doi: 10.1152/ajpendo.00166.2025. Epub 2025 Jul 7.

The close relationship between trace elements (Cu, Fe, Zn, Se, Rb, Si, Cr, and V) and Alzheimer's disease: Research progress and insights

Mao Y, Zhang L, Zhang C, Qin L, Liao X, Zhao L.

J Trace Elem Med Biol. 2025 Aug;90:127692. doi: 10.1016/j.jtemb.2025.127692. Epub 2025 Jul 3.

Gut microbiota-driven neuroinflammation in Alzheimer's disease: from mechanisms to therapeutic opportunities

Lei W, Cheng Y, Liu X, Gao J, Zhu Z, Ding W, Xu X, Li Y, Ling Z, Jiang R, Chen X.

Front Immunol. 2025 Jun 26;16:1582119. doi: 10.3389/fimmu.2025.1582119. eCollection 2025.

Natural Products and Exercise Synergy: Unraveling Molecular Mechanisms to Enhance Brain Function in Alzheimer's Disease

Chen L, Wang X, Zheng Q, Wang H.

Phytother Res. 2025 Aug;39(8):3800-3812. doi: 10.1002/ptr.70005. Epub 2025 Jul 11.

Glial Cells in Alzheimer's Disease: Pathogenic Mechanisms and Therapeutic Frontiers

Sil M, Mukherjee N, Chatterjee I, Ghosh A, Goswami A.

J Mol Neurosci. 2025 Jul 12;75(3):87. doi: 10.1007/s12031-025-02379-8.

APOE4-driven lipid metabolic dysregulation in Alzheimer's disease: Multi-pathway mechanisms and therapeutic perspectives

Zhang WX, Yang YL, Yu JX, Jia LH, Huang HC.

Biochem Biophys Res Commun. 2025 Sep 8;778:152335. doi: 10.1016/j.bbrc.2025.152335. Epub 2025 Jul 10.

Amyloid and tau pathologies cross-talk to promote Alzheimeŕs disease: novel mechanistic insights

Avila J, Hernández F, Perry G.

Neuroscience. 2025 Aug 30;582:58-62. doi: 10.1016/j.neuroscience.2025.07.025. Epub 2025 Jul 17.

Neutral pH-Selective Inhibition of Cytosolic Cathepsin B: A Novel Drug Targeting Strategy for Traumatic Brain Injury and Alzheimer's Disease

Hook V, Podvin S, Yoon MC, Phan VV, Florio J, Spencer B, Mosier C, Cheng A, Ahuett S, Almaliti J, Gerwick WH, Rissman RA, O'Donoghue AJ.

ACS Chem Biol. 2025 Aug 15;20(8):1841-1848. doi: 10.1021/acschembio.5c00463. Epub 2025 Jul 23.

Autophagy and Cellular Senescence in Alzheimer's Disease: Key Drivers of Neurodegeneration

Hussain MS, Agrawal N, Ilma B, M M R, Nayak PP, Kaur M, Khachi A, Goyal K, Rekha A, Gupta S, Gupta G, Dua K.

CNS Neurosci Ther. 2025 Jul;31(7):e70503. doi: 10.1111/cns.70503.

Advances in mesenchymal stem cell and exosome-based therapies for aging and age-related diseases

Li H, Bai L.

Stem Cell Res Ther. 2025 Jul 26;16(1):401. doi: 10.1186/s13287-025-04318-1.

Mitochondrial Damage and Autophagy Dysregulation in Alzheimer's Disease: Mechanisms and Therapeutic Opportunities

Yu Q, Li L, Yu S, Han J, Cheng Q, Cui Z, Chen H, Li M, Lu Z.

Neurochem Res. 2025 Jul 28;50(4):251. doi: 10.1007/s11064-025-04490-z.

Dual Inhibitors of Acetylcholinesterase and Monoamine Oxidase-B for the Treatment of Alzheimer's Disease

Asim A, Jastrzębski MK, Kaczor AA.

Molecules. 2025 Jul 15;30(14):2975. doi: 10.3390/molecules30142975.

A synapse perspective on the function of the amyloid precursor protein

Kruse P, Eichler A, Klukas L, Lenz M.

Sci Prog. 2025 Jul-Sep;108(3):368504251360728. doi: 10.1177/00368504251360728. Epub 2025 Jul 30.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias